Lv1
10 积分 2021-08-16 加入
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
11小时前
待确认
Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma
5个月前
已完结
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance
7个月前
已完结
皖公网安备34019202002308
